Nurse Practitioner, Family · Montgomery, AL
NPI
1871931832
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1722 Pine St Ste 204
Montgomery, AL, 36106
Phone (334) 293-6825
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
521 services
Medicare patients, 2024
384
Average age 73
Drug cost, 2024
$585K
3,214 prescriptions
Company payments, 2025
$1,101
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carla L de la Garza was code 99214 (office e&m - established), 228 times for 166 patients. In total Carla L de la Garza billed 521 services in 9 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 228 | 166 | $52.25 | $12K |
| 99214 Office E&M - Established | Office | 74 | 59 | $52.17 | $3,861 |
| 99204 Office E&M - New | Facility | 53 | 53 | $67.30 | $3,567 |
| 99213 Office E&M - Established | Facility | 49 | 49 | $33.26 | $1,630 |
| 99203 Office E&M - New | Facility | 42 | 42 | $36.52 | $1,534 |
| 99203 Office E&M - New | Office | 20 | 20 | $34.18 | $684 |
| 99213 Office E&M - Established | Office | 17 | 16 | $40.92 | $696 |
| 99204 Office E&M - New | Office | 16 | 16 | $80.34 | $1,285 |
By year: 2022 $16K for 344 services; 2023 $9,055 for 139 services; 2024 $27K for 521 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carla L de la Garza prescribed most often to Medicare patients was Famotidine, with 620 prescriptions and refills. In total Carla L de la Garza wrote 3,214 Medicare prescriptions that cost $585K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 620 | 1,758 | 248 | $16K |
| Pantoprazole Sodium Generic | 474 | 1,309 | 203 | $7,423 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 306 | 306 | 293 | $4,921 |
| Linzess Linaclotide | 211 | 418 | 83 | $224K |
| Omeprazole Generic | 177 | 507 | 82 | $4,310 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 124 | 124 | 121 | $2,068 |
| Dicyclomine Hcl Generic | 123 | 161 | 47 | $3,721 |
| Lubiprostone Generic | 96 | 199 | 41 | $14K |
| Lactulose Generic | 89 | 179 | 47 | $1,587 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 72 | 72 | 71 | $9,926 |
| Lansoprazole Generic | 56 | 136 | 22 | $2,449 |
| Rabeprazole Sodium Generic | 52 | 146 | 20 | $3,271 |
| Metronidazole Generic | 48 | 48 | 40 | $522 |
| Esomeprazole Magnesium Generic | 48 | 129 | 17 | $5,451 |
| Ondansetron Hcl Generic | 48 | 49 | 30 | $580 |
Brand drugs: 611 claims; generic drugs: 2,603 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carla L de la Garza $1,101 ($1,101 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $421.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $421 |
| Genzyme Corporation SNY | 8 | $140 |
| Ardelyx, Inc. ARDX | 5 | $112 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $74.12 |
| Lilly USA, LLC LLY | 3 | $59.82 |
| Pfizer Inc. PFE | 3 | $54.47 |
| Janssen Biotech, Inc. JNJ | 3 | $52.86 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $37.65 |
| Madrigal Pharmaceuticals MDGL | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $23.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.